| Evolv Technologies Holdings, Inc. |
10%+ Owner |
Class A Common Stock |
12,774,845 |
$53,909,846 |
$4.22 |
16 Jul 2021 |
By General Catalyst Group V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Common Stock |
4,784,323 |
$13,872,623 |
$2.90 |
06 Feb 2024 |
Directly held by General Catalyst Group V, L.P. |
| Evolv Technologies Holdings, Inc. |
10%+ Owner |
Class A Common Stock |
279,438 |
$1,179,228 |
$4.22 |
16 Jul 2021 |
By General Catalyst Group V, Supplemental, L.P. |
| Evolv Technologies Holdings, Inc. |
10%+ Owner |
Class A Common Stock |
271,865 |
$1,147,270 |
$4.22 |
16 Jul 2021 |
By GC Entrepreneurs Fund V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Common Stock |
99,863 |
$289,563 |
$2.90 |
06 Feb 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by General Catalyst Group V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by General Catalyst Group V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series C-1 Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series C-1 Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by General Catalyst Group V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series C-2 Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series C-2 Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by General Catalyst Group V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series D Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series D Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by General Catalyst Group V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series E Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
| Fractyl Health, Inc. |
10%+ Owner |
Series E Preferred Stock |
0 |
|
|
06 Feb 2024 |
Directly held by General Catalyst Group V, L.P. |